argus

Aarti Drugs Limited

NSE: AARTIDRUGSINE767A010163,809 Cr

Timeline

Time (IST)TypeMEventSrc
02 Sept, 09:58 pmother0Aarti Drugs Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for FY 2025-26'.nse
02 Sept, 09:39 pmprocedural0Filing of the Annual Report for FY 2025-26.bse
27 Aug, 12:46 pmAarti Drugs Ltd - 524348 - Board Meeting Outcome for Approval Of Aarti Drugs Limited Performance Stock Option Plan 2026bse
27 Aug, 12:45 pmAarti Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2026.nse
24 Aug, 09:48 pmAarti Drugs Ltd - 524348 - Board Meeting Intimation for ''Aarti Drugs Limited - Performance Stock Option Plan 2026',bse
10 Aug, 09:34 pmAarti Drugs Ltd - 524348 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")bse
10 Aug, 09:34 pmAarti Drugs Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
07 Aug, 08:35 pmAarti Drugs Limited has informed the Exchange about Transcriptnse
07 Aug, 08:35 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
03 Aug, 07:24 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
03 Aug, 07:24 pmAarti Drugs Limited has informed the Exchange about Link of Recordingnse
01 Aug, 05:22 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
01 Aug, 05:20 pmAarti Drugs Limited has informed the Exchange about Investor Presentationnse
01 Aug, 05:16 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
01 Aug, 05:12 pmAarti Drugs Limited has informed the Exchange regarding a press release dated August 01, 2026, titled "Q1FY27 Business & Financial Performance".nse
01 Aug, 04:34 pmAarti Drugs Ltd - 524348 - Revocation Of Closure Order By GPCB Related To Plant Located At Sayakhabse
01 Aug, 04:31 pmAarti Drugs Limited has informed the Exchange about Action(s) taken or orders passednse
31 Jul, 10:10 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
31 Jul, 10:10 pmAarti Drugs Limited has informed the Exchange regarding a press release dated July 31, 2026, titled "Aarti Drugs Limited Announces Leadership Transition to Strengthen Governance and Ensure Long-Term Strategic Growth".nse
31 Jul, 08:10 pmAarti Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on July 31, 2026.nse
31 Jul, 08:10 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
31 Jul, 07:22 pmAarti Drugs Ltd - 524348 - Board Meeting Outcome for Financial Results For The Quarter Ended June 30, 2026bse
31 Jul, 07:20 pmAarti Drugs Ltd - 524348 - Financial Results For The Quarter Ended June 30, 2026bse
31 Jul, 07:20 pmAarti Drugs Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
24 Jul, 07:25 pmAarti Drugs Ltd - 524348 - Board Meeting Intimation for Considering The Financial Results For The Quarter Ended June 30, 2026bse
18 Jul, 10:40 pmAarti Drugs Ltd - 524348 - Closure Directions By GPCBbse
18 Jul, 10:40 pmAarti Drugs Limited has informed the Exchange about Action(s) taken or orders passednse
06 Jul, 03:04 pmHarshit M. Savla has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
01 Jul, 12:50 pmHarshit M. Savla has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
27 Jun, 04:30 pmAarti Drugs Ltd - 524348 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
26 May, 08:55 pmAarti Drugs Ltd - 524348 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
23 May, 11:35 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
23 May, 11:35 pmAarti Drugs Limited has informed the Exchange about Transcriptnse
18 May, 04:03 pmAarti Drugs Limited has informed the Exchange about Link of Recordingnse
18 May, 04:01 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
16 May, 02:46 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
16 May, 02:43 pmAarti Drugs Limited has informed the Exchange about Investor Presentationnse
16 May, 02:40 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
16 May, 02:33 pmAarti Drugs Limited has informed the Exchange regarding a press release dated May 16, 2026, titled "Q4&FY26 Business and Financial Performance".nse
15 May, 06:53 pmAarti Drugs Limited has informed the Exchange about General Updates - Re-appointment of Cost Auditor and Internal Auditornse
15 May, 06:45 pmAarti Drugs Ltd - 524348 - Board Meeting Outcome for Outcome Of The Board Meeting Dated May 15, 2026bse
15 May, 06:33 pmAarti Drugs Ltd - 524348 - Financial Results For The Quarter And Year Ended March 31, 2026bse
15 May, 06:26 pmAarti Drugs Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
08 May, 07:17 pmAarti Drugs Ltd - 524348 - Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended March 31, 2026bse
06 Apr, 02:57 pmAarti Drugs Limited has informed the Exchange regarding a press release dated April 06, 2026, titled "Second 100 days Campaign".nse
06 Apr, 02:46 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
24 Mar, 06:18 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
24 Mar, 06:17 pmAarti Drugs Limited has informed the Exchange about Credit Ratingnse
16 Mar, 08:26 pmAarti Drugs Ltd - 524348 - Disclosure Under Regulation 30 Of SEBI Listing Regulationsbse
16 Mar, 08:26 pmAarti Drugs Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse